Invention Grant
- Patent Title: Single domain antibodies directed against STAT3
-
Application No.: US14922093Application Date: 2015-10-23
-
Publication No.: US09695234B2Publication Date: 2017-07-04
- Inventor: Sunanda Singh
- Applicant: SINGH MOLECULAR MEDICINE, LLC
- Applicant Address: US FL Tampa
- Assignee: SINGH MOLECULAR MEDICINE, LLC
- Current Assignee: SINGH MOLECULAR MEDICINE, LLC
- Current Assignee Address: US FL Tampa
- Agency: Leech Tishman Fuscaldo & Lampl
- Agent Laura M. Lloyd
- Main IPC: C07K16/18
- IPC: C07K16/18 ; C07K16/24 ; A61K39/395 ; A61K45/06 ; G01N33/68 ; C07K16/32 ; C07K16/42 ; C07K16/30 ; C07K16/40 ; G01N33/574 ; G01N33/94 ; A61K39/00

Abstract:
This invention provides compositions and methods to treat a condition or disease without the use of exogenous targeting sequences or chemical compositions. The present invention relates to single-domain antibodies (sdAbs), proteins and polypeptides comprising the sdAbs that are directed against intracellular components that cause a condition or disease. The invention also includes nucleic acids encoding the sdAbs, proteins and polypeptides, and compositions comprising the sdAbs. The invention includes the use of the compositions, sdAbs, and nucleic acids encoding the sdAbs for prophylactic, therapeutic or diagnostic purposes.
Public/Granted literature
- US20160115248A1 SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST STAT3 Public/Granted day:2016-04-28
Information query